Additionally, the in vitro experiments revealed that CtBP2 knockdown reversed GLI1/SNAI1 driven EMT, but CtBP2 could not induce EMT in HCC cells without SNAI1 expression. Here, GLI1 is linked to hepatocellular carcinoma.